HK1211023A1 - Pde9i with imidazo pyrazinone backbone pde9i - Google Patents

Pde9i with imidazo pyrazinone backbone pde9i

Info

Publication number
HK1211023A1
HK1211023A1 HK15111740.3A HK15111740A HK1211023A1 HK 1211023 A1 HK1211023 A1 HK 1211023A1 HK 15111740 A HK15111740 A HK 15111740A HK 1211023 A1 HK1211023 A1 HK 1211023A1
Authority
HK
Hong Kong
Prior art keywords
pde9i
backbone
imidazo
imidazo pyrazinone
pyrazinone backbone
Prior art date
Application number
HK15111740.3A
Other languages
English (en)
Chinese (zh)
Inventor
Niels Svenstrup
Klaus Bk Simonsen
Lars Kyhn Rasmussen
Karsten Juhl
Morten Langgard
Kate Wen
Yazhou Wang
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HK1211023A1 publication Critical patent/HK1211023A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15111740.3A 2011-10-10 2015-11-27 Pde9i with imidazo pyrazinone backbone pde9i HK1211023A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2011001692 2011-10-10
PCT/EP2012/069936 WO2013053690A1 (en) 2011-10-10 2012-10-09 Pde9i with imidazo pyrazinone backbone

Publications (1)

Publication Number Publication Date
HK1211023A1 true HK1211023A1 (en) 2016-05-13

Family

ID=47019007

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111740.3A HK1211023A1 (en) 2011-10-10 2015-11-27 Pde9i with imidazo pyrazinone backbone pde9i

Country Status (15)

Country Link
US (2) US9643970B2 (hu)
EP (2) EP3121178B1 (hu)
JP (1) JP2015531401A (hu)
CN (2) CN106905324B (hu)
AU (2) AU2012323085B2 (hu)
BR (1) BR112015007731B1 (hu)
CA (1) CA2886885C (hu)
HK (1) HK1211023A1 (hu)
IL (2) IL237836A (hu)
IN (1) IN2015DN02829A (hu)
MA (1) MA37958B1 (hu)
MX (1) MX370433B (hu)
SG (1) SG11201502728WA (hu)
TN (1) TN2015000100A1 (hu)
WO (1) WO2013053690A1 (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905324B (zh) * 2011-10-10 2018-09-25 H.隆德贝克有限公司 具有咪唑并吡嗪酮骨架的pde9抑制剂
LT3105226T (lt) 2014-02-13 2019-11-11 Incyte Corp Ciklopropilaminai, kaip lsd1 inhibitoriai
US9493442B2 (en) 2014-02-13 2016-11-15 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
PL3105218T3 (pl) 2014-02-13 2020-03-31 Incyte Corporation Cyklopropyloaminy jako inhibitory lsd1
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
TW201629064A (zh) 2014-10-10 2016-08-16 H 朗德貝克公司 作爲pde1抑制劑之三唑並吡酮
EP3277689B1 (en) 2015-04-03 2019-09-04 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
JO3627B1 (ar) * 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
DK3303339T3 (da) * 2015-07-07 2021-04-12 H Lundbeck As Pde9-inhibitorer med imidazotriazinonskelet og imidazopyrazinonskelet til behandling af perifere sygdomme
TW201717948A (zh) * 2015-08-10 2017-06-01 H 朗德貝克公司 包括給予2-胺基-3,5,5-三氟-3,4,5,6-四氫吡啶的聯合治療
SG10202001219UA (en) 2015-08-12 2020-03-30 Incyte Corp Salts of an lsd1 inhibitor
JP6877423B2 (ja) * 2015-11-09 2021-05-26 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag がんの処置において有用なジヒドロイミダゾピラジノン誘導体
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商H 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
PE20190377A1 (es) 2016-04-22 2019-03-08 Incyte Corp Formulaciones de un inhibidor de lsd 1
CN114903900A (zh) * 2016-07-06 2022-08-16 伊马拉公司 用于治疗外周疾病的pde9抑制剂
CN109843884B (zh) * 2016-10-18 2022-03-04 H.隆德贝克有限公司 作为pde1抑制剂的咪唑并吡嗪酮、吡唑并嘧啶酮和吡唑并吡啶酮
CA3041595A1 (en) * 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising administration of imidazopyrazinones
EP3532064B1 (en) * 2016-10-28 2020-07-29 H. Lundbeck A/S Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
WO2018154133A1 (en) * 2017-02-27 2018-08-30 Janssen Pharmaceutica Nv [1,2,4]-triazolo [1,5-a]-pyrimidinyl derivatives substituted with piperidine, morpholine or piperazine as oga inhibitors
IL270792B2 (en) * 2017-05-26 2024-01-01 Imara Inc Methods for the preparation and use of PDE9 inhibitors
CN111051308A (zh) 2017-06-08 2020-04-21 默沙东公司 吡唑并嘧啶pde9抑制剂
EP3713936B1 (en) 2017-11-23 2021-10-20 Basf Se Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
JP2021526134A (ja) 2018-05-25 2021-09-30 イマラ インク. 6−[(3S,4S)−4−メチル−l−(ピリミジン−2−イルメチル)ピロリジン−3−イル]−3−テトラヒドロピラン−4−イル−7H−イミダゾ[l,5−A]ピラジン−8−オンの一水和物および結晶形態
CN112312908A (zh) * 2018-06-20 2021-02-02 詹森药业有限公司 Oga抑制剂化合物
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
CN114302724A (zh) * 2019-04-05 2022-04-08 伊马拉公司 用于治疗镰状细胞病的pde9抑制剂
CN114072151A (zh) * 2019-05-07 2022-02-18 伊马拉公司 用于治疗地中海贫血的pde9抑制剂
WO2022036111A1 (en) * 2020-08-13 2022-02-17 Imara Inc. Methods and compositions for treating sickle cell disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230154B1 (hu) 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
AU2291200A (en) 1999-01-20 2000-08-07 Arzneimittelwerk Dresden Gmbh Use of imidazo(1,5-a)-pyrido(3,2-e)-pyrazinones as medicaments
HN2002000317A (es) * 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
KR20040053210A (ko) 2001-11-02 2004-06-23 화이자 프로덕츠 인크. Pde9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
GB2388111A (en) 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
US20040220186A1 (en) 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
CA2543522A1 (en) 2003-10-31 2005-05-12 Pfizer Products Inc. Phosphodiesterase 9 inhibition as treatment for obesity-related conditions
TW200800213A (en) 2005-09-02 2008-01-01 Abbott Lab Novel imidazo based heterocycles
TW200815436A (en) 2006-05-30 2008-04-01 Elbion Ag 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
WO2008029589A1 (fr) 2006-09-08 2008-03-13 Tokuyama Corporation Procédé et matériel servant à produire un nitrure d'un élément du groupe iii
EP2103613B1 (en) 2006-12-13 2016-02-17 ASKA Pharmaceutical Co., Ltd. Quinoxaline derivative
US20100113484A1 (en) 2006-12-13 2010-05-06 Aska Pharmaceutical Co., Ltd. Treating agent of uropathy
ME00954B (me) 2007-05-11 2012-06-20 Pfizer Aminoheterociklični spojevi
DE102007032349A1 (de) 2007-07-11 2009-01-15 Bayer Healthcare Ag Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
TWI404721B (zh) 2009-01-26 2013-08-11 Pfizer 胺基-雜環化合物
US9260432B2 (en) 2009-09-02 2016-02-16 Concert Pharmaceuticals, Inc. Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
JP5855109B2 (ja) 2010-09-20 2016-02-09 フォーラム・ファーマシューティカルズ・インコーポレイテッドForum Pharmaceuticals Inc. イミダゾトリアジノン化合物
HUE028555T2 (hu) 2011-10-07 2016-12-28 Eisai R&D Man Co Ltd Pirazolokinolin-származékok mint PDE9 inhibitorok
CN106905324B (zh) * 2011-10-10 2018-09-25 H.隆德贝克有限公司 具有咪唑并吡嗪酮骨架的pde9抑制剂
EP2807163B1 (en) 2012-01-26 2017-03-22 H. Lundbeck A/S Pde9 inhibitors with imidazo triazinone backbone
EP2828262A4 (en) 2012-03-19 2015-09-23 Forum Pharmaceuticals Inc IMIDAZOTRIAZINONVERBINDUNGEN

Also Published As

Publication number Publication date
US9643970B2 (en) 2017-05-09
EP2906562A1 (en) 2015-08-19
MA37958A1 (fr) 2017-11-30
CN106905324A (zh) 2017-06-30
IL253448A0 (en) 2017-09-28
US20170173018A1 (en) 2017-06-22
AU2012323085B2 (en) 2017-03-09
JP2015531401A (ja) 2015-11-02
AU2017201873C1 (en) 2018-08-02
MA37958B1 (fr) 2018-10-31
BR112015007731A2 (pt) 2017-07-04
EP2906562B1 (en) 2016-10-05
CN104703987A (zh) 2015-06-10
MX2015004422A (es) 2015-10-15
CA2886885C (en) 2019-07-16
AU2017201873A1 (en) 2017-04-06
EP3121178A1 (en) 2017-01-25
CN104703987B (zh) 2017-05-03
SG11201502728WA (en) 2015-05-28
IL237836A (en) 2017-07-31
AU2012323085A1 (en) 2015-04-02
CN106905324B (zh) 2018-09-25
CA2886885A1 (en) 2013-04-18
WO2013053690A1 (en) 2013-04-18
MX370433B (es) 2019-12-13
US9993477B2 (en) 2018-06-12
US20150274736A1 (en) 2015-10-01
EP3121178B1 (en) 2018-09-19
IN2015DN02829A (hu) 2015-09-11
TN2015000100A1 (en) 2016-06-29
AU2017201873B2 (en) 2018-03-29
BR112015007731B1 (pt) 2022-05-31

Similar Documents

Publication Publication Date Title
IL253448A0 (en) Pde91 is an imidazo- pyrazinone backbone
HK1245491A1 (zh) 計算機可讀介質
HK1199879A1 (en) Pde9 inhibitors with imidazo triazinone backbone pde9
EP2739857A4 (en) BLOWER
ZA201305720B (en) Stable bio-oil
IL230997A0 (en) 10pde pyrimidine inhibitors
EP3701800C0 (en) USE
HK1187614A1 (zh) 咪唑並吡嗪
SI2525128T1 (sl) Prehodni kos
EP2691581A4 (en) joint assembly
SI2771327T1 (sl) Novi pirazinski derivati
ZA201304139B (en) Combination
PL2606715T3 (pl) Kombinacja prasująco-owijająca
PL2586945T3 (pl) Wózek
PL2713822T3 (pl) Układ przesuwny
EP2693834A4 (en) HEATING ELEMENT
IL227377A0 (en) Combinations
GB2512771B (en) Ablutionary fitting
PL2550905T3 (pl) Mikser ręczny
EP2672969A4 (en) ASSOCIATION
PL120058U1 (pl) Zespól progowy
AU337435S (en) Bookcase
GB201106034D0 (en) Heater
AU338048S (en) Stool
AU336684S (en) Stool